(Q39603175)

13 September 2017

1 reference

title

High-density lipoprotein: a major risk factor for coronary atherosclerosis (English)

1 reference

13 September 2017

0 references

0 references

1 reference

1 reference

Miller NE

1

1 reference

13 September 2017

publication date

1 August 1987

1 reference

Bailliere's clinical endocrinology and metabolism

13 September 2017

published in

1 reference

13 September 2017

volume

1

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

603-622

1 reference

Diet, lipoproteins and the progression of coronary atherosclerosis. The Leiden Intervention Trial

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

High-density lipoprotein cholesterol and prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Hyperalphalipoproteinaemic activity of BRL 26314--II. Inhibition of atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

High density lipoprotein cholesterol: prognosis after myocardial infarction. The Israeli Ischemic Heart Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Timolol maleate and HDL cholesterol after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

A DNA insertion in the apolipoprotein A-I gene of patients with premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

On the associations of body cholesterol pool size with age, HDL cholesterol and plasma total cholesterol concentration in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Effects of adrenoceptor-blocking drugs on plasma lipoprotein concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Cholesterol kinetics and faecal steroid excretion in subjects with primary hyperalphalipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

Are plasma lipoprotein cholesteryl esters utilized for biliary cholesterol and bile acid production in man?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

The anatomy and physiology of reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2887%2980025-3

7 January 2021

10.1016/S0950-351X(87)80025-3

Identifiers

DOI

1 reference

13 September 2017

1 reference